Opsonizing antibodies mediated SARS-CoV-2 entry into monocytes leads to inflammation.
Opsonizing antibodies mediated SARS-CoV-2 entry into monocytes leads to inflammation.
复制标题
调理抗体介导 SARS-CoV-2 进入单核细胞导致炎症
DOI:
10.1002/mef2.11
复制
发表时间:
2022-06
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
A recent paper published in Nature by Caroline Junqueira et al.(2022) 1 reveals that FcγR and opsonizing antibodies can mediate severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection of monocytes/macrophages, which can then activate NLRP3 inflammasomes, caspase‐1, and Gasdermin D (GSDMD), and thereby trigger pyroptosis and severe inflammatory reaction.Since the first description in late 2019, coronavirus disease 2019 (COVID‐19), caused by RS‐CoV‐2, has emerged as one of the most significant global public health crises. In some patients, SARS‐CoV‐2 infection can induce a severe inflammatory cytokine storm that can lead to respiratory syndrome and multiorgan failure. 1, 2 From a biological perspective, when myeloid cells sense invasive infection, they activate inflammasomes, which recruit apoptotic speck protein containing a caspase recruitment domain (ASC) adaptors and further activate downstream caspase‐1, which cleaves the suppressant C‐domain and releases